Peripheral blood CD26+ leukemic stem cells in chronic myeloid leukemia and tyrosine kinase inhibitor response: Questions remain!

Cancer. 2025 Dec 15;131(24):e70215. doi: 10.1002/cncr.70215.
No abstract available

Publication types

  • Letter